GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenway Greenhouse Cannabis Corp (XCNQ:GWAY) » Definitions » Debt-to-Revenue

Greenway Greenhouse Cannabis (XCNQ:GWAY) Debt-to-Revenue : 2.90 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Greenway Greenhouse Cannabis Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Greenway Greenhouse Cannabis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.37 Mil. Greenway Greenhouse Cannabis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$15.73 Mil. Greenway Greenhouse Cannabis's annualized Revenue for the quarter that ended in Dec. 2023 was C$5.55 Mil. Greenway Greenhouse Cannabis's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 2.90.


Greenway Greenhouse Cannabis Debt-to-Revenue Historical Data

The historical data trend for Greenway Greenhouse Cannabis's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenway Greenhouse Cannabis Debt-to-Revenue Chart

Greenway Greenhouse Cannabis Annual Data
Trend Mar21 Mar22 Mar23
Debt-to-Revenue
N/A 8.40 2.48

Greenway Greenhouse Cannabis Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.86 4.63 2.57 2.91 2.90

Competitive Comparison of Greenway Greenhouse Cannabis's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenway Greenhouse Cannabis's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Greenway Greenhouse Cannabis's Debt-to-Revenue falls into.



Greenway Greenhouse Cannabis Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Greenway Greenhouse Cannabis's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.39 + 13.567) / 5.622
=2.48

Greenway Greenhouse Cannabis's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.368 + 15.726) / 5.552
=2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Greenway Greenhouse Cannabis Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Greenway Greenhouse Cannabis's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenway Greenhouse Cannabis (XCNQ:GWAY) Business Description

Traded in Other Exchanges
Address
1478 Seacliff Drive, Kingsville, ON, CAN, N9Y 2M2
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.

Greenway Greenhouse Cannabis (XCNQ:GWAY) Headlines

No Headlines